Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Vepalimomab: Difference between pages
(Difference between pages)
Content deleted Content added
Saving copy of the {{drugbox}} taken from revid 460520610 of page Vepalimomab for the Chem/Drugbox validation project (updated: 'CAS_number'). |
Entranced98 (talk | contribs) Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound" |
||
| Line 1: | Line 1: | ||
| ⚫ | |||
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Vepalimomab|oldid=460520610}} 460520610] of page [[Vepalimomab]] with values updated to verified values.}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = 470629578 |
||
| image = |
| image = |
||
<!-- Monoclonal antibody data --> |
|||
| ⚫ | |||
| type = mab |
| type = mab |
||
| mab_type = mab |
| mab_type = mab |
||
| source = o |
| source = o |
||
| target = [[Vascular adhesion protein|VAP-1]] |
| target = [[Vascular adhesion protein|VAP-1]] |
||
| ⚫ | |||
| ⚫ | |||
| tradename = |
| tradename = |
||
| pregnancy_AU = |
| pregnancy_AU = |
||
| Line 22: | Line 20: | ||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
| ⚫ | |||
| ⚫ | |||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| Line 29: | Line 26: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
| ⚫ | |||
| ⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
||
| ChemSpiderID = |
| ChemSpiderID = none |
||
| CAS_number_Ref = {{cascite| |
| CAS_number_Ref = {{cascite|changed|??}} |
||
| CAS_number = |
| CAS_number = 195158-85-1 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 0M19J59UH4 |
|||
| ATC_prefix = none |
| ATC_prefix = none |
||
| ATC_suffix = |
| ATC_suffix = |
||
| Line 40: | Line 38: | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = |
||
| ⚫ | |||
| ⚫ | |||
| chemical_formula = |
| chemical_formula = |
||
| molecular_weight = |
| molecular_weight = |
||
}} |
}} |
||
'''Vepalimomab''' is an experimental [[mouse]] [[monoclonal antibody]] intended for the treatment of [[inflammation]]s. It blocks [[vascular adhesion protein 1]].<ref>{{cite journal | vauthors = Vainio PJ, Kortekangas-Savolainen O, Mikkola JH, Jaakkola K, Kalimo K, Jalkanen S, Veromaa T | title = Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis | journal = Basic & Clinical Pharmacology & Toxicology | volume = 96 | issue = 6 | pages = 429–35 | date = June 2005 | pmid = 15910406 | doi = 10.1111/j.1742-7843.2005.pto_05.x | doi-access = free }}</ref> Development of the drug was discontinued in 2002.<ref>{{cite web |title=Vepalimomab | work = AdisInsight |url=https://adisinsight.springer.com/drugs/800016990 | publisher = Springer Nature Switzerland AG }}</ref> |
|||
== References == |
|||
{{reflist}} |
|||
{{immunosuppressants}} |
|||
{{Monoclonals for immune system}} |
|||
[[Category:Monoclonal antibodies]] |
|||
[[Category:Abandoned drugs]] |
|||
{{monoclonal-antibody-stub}} |
|||
{{antineoplastic-drug-stub}} |
|||